Article
type: Class

Document
type: Class

Academic Article
type: Class

Information Content Entity
type: Class

5730341
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) for patients with advanced pancreatic cancer: The ghost regimen

Continuant
type: Class

PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) for patients with advanced pancreatic cancer: The ghost regimen
type: Article
type: Document
related by: 5730341
most specific type: Academic Article
type: Continuant
type: Thing
type: Entity
type: Generically Dependent Continuant
type: Academic Article
type: Information Content Entity

Entity
type: Class

RDF description of PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) for patients with advanced pancreatic cancer: The ghost regimen - http://irises.unisr.it/resource/item/104051
rights: termsOfUse
date: 2026-08-24T06:35:23
publisher: PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) for patients with advanced pancreatic cancer: The ghost regimen
type: Document

Generically Dependent Continuant
type: Class